We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
STFYAYB provides information about the screening tests offered during and after pregnancy.
This short animation shows the screening tests offered during pregnancy…
This short animation explains why screening for infectious diseases in…
This short animation explains screening for sickle cell and thalassaemia…
This short animation explains screening for Down’s syndrome, Edwards’…
This short video explains screening for 11 physical conditions in…
Diabetic eye screening is recommended by the NHS. 1. Purpose of screening…
This short video explains screening for eyes, heart, hips and testicles in…
This short video explains screening for hearing loss in newborn babies.…
This short video explains blood spot screening for newborn babies. Blood…
These 8 easy read guides explain the screening tests offered during and after pregnancy for people with learning disabilities.
The processes for managing safety incidents in the NHS screening programmes.
The Patient Safety Incident Response Framework will replace the Serious…
A Adverse event An event or omission arising during clinical care and…
This overview is aimed at professionals working in the NHS newborn blood spot (NBS) screening programme.
Guidance for local NHS screening services on how to order printed population screening leaflets.
Information for parents and carers who are offered screening for severe combined immunodeficiency (SCID) for their babies.
Resources to support screening professionals in their initial training and continuing professional development (CPD).
Information and advice for parents of babies with suspected spinal muscular atrophy (SMA) following newborn blood spot screening.
These FAQs explain spinal muscular atrophy (SMA), the benefits and limits of early treatment, how screening will work, and what families can expect.
Role and remit of NHS population screening programmes’ Research, Innovation and Development Advisory Committee
How to support patients in accessing population screening programmes and obtaining screening results.
These documents explain how to take a newborn blood spot screening sample.
This guidance explains what is required of health professionals carrying out newborn blood spot (NBS) screening.
Requirements for the quality assurance of laboratories providing antenatal and newborn screening services by the United Kingdom Accreditation Service (UKAS).
Screening standards for the NHS newborn blood spot (NBS) screening programme.
Provides the code of practice for the retention and storage of residual spots after newborn blood spot testing.
Guidance to support the health system to reduce inequalities in screening.
How to use the newborn blood spot screening failsafe solution (NBSFS), the national IT system, to minimise risk to babies.
This document explains the guidelines for laboratories screening newborns for cystic fibrosis (CF) in the UK.
Laboratories can use this template to refer babies with a screen-positive result for SMA to the relevant regional neuromuscular centre (RNMC).
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).